{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T06:41:42Z","timestamp":1787380902708,"version":"build-2736575974"},"reference-count":176,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background\/Objectives: Obesity is a multifactorial chronic condition characterized by the accumulation of excess adiposity and complex interplay between intrinsic and extrinsic factors. It is an increasingly common condition, closely implicated with the incidence and progression of cardiovascular disease and its risk factors. This narrative review synthesizes and summarizes recent evidence on obesity, with a focus on the diagnosis of obesity, an exploration of both visceral and subcutaneous adipose tissue, available interventions for obesity ranging from dietary modifications to novel anti-obesity medications, and key associations with obesity and cardiovascular diseases. This review is distinct in its integrated focus on obesity definition and diagnosis, imaging modalities, the latest non-pharmacologic and pharmacologic interventions, and also the interplay between obesity and certain cardiovascular conditions as well as their risk factors. Results: The diagnosis of obesity has been evolving with the incorporation of anthropometric measurements and imaging modalities rather than simply the body mass index. There is a wide array of contributors to obesity including genetic factors, behavior, hormonal regulators, the brain\u2013gut axis, and psychosocial stressors. Anti-obesity medications have been evolving rapidly, with current emphasis on glucagon-like peptide 1 receptor agonists. Obesity is closely implicated in cardiovascular conditions such as atherosclerotic disease, heart failure, atrial fibrillation, and hypertension as well as related risk factors such as diabetes mellitus, chronic kidney disease and sleep apnea. Conclusions: Obesity is a widely prevalent, chronic, and complex disease. The use of a variety of anthropometric measurements can help risk-stratify individuals. Imaging techniques are also helpful in evaluating body fat. Evaluating individuals from a holistic perspective is imperative to appreciate the various contributors to obesity. There are a variety of interventions available for obesity management including lifestyle interventions, bariatric surgery, and pharmacologic therapy. Notably, obesity is closely tied with cardiovascular diseases and recent pharmacologic anti-obesity agents may mitigate cardiovascular risk.<\/jats:p>","DOI":"10.3390\/jcm15124430","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T16:25:16Z","timestamp":1780935916000},"page":"4430","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Update on Obesity and Its Relationship to Atherosclerotic Cardiovascular Disease and Associated Risk Factors"],"prefix":"10.3390","volume":"15","author":[{"given":"Yaser","family":"Ahmad","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raj","family":"Wasan","sequence":"additional","affiliation":[{"name":"College of William and Mary, Williamsburg, VA 23185, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan D.","family":"Perchik","sequence":"additional","affiliation":[{"name":"Department of Radiology, University of Alabama at Birmingham, Birmingham, AL 35294, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9657-5620","authenticated-orcid":false,"given":"Navin C.","family":"Nanda","sequence":"additional","affiliation":[{"name":"Division of Cardiology, University of Alabama at Birmingham, Birmingham, AL 35294, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1093\/eurheartj\/ehae508","article-title":"Obesity and cardiovascular disease: An ESC clinical consensus statement","volume":"45","author":"Koskinas","year":"2024","journal-title":"Eur. Heart J."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Jani\u0107, M., Jane\u017e, A., El-Tanani, M., and Rizzo, M. (2025). Obesity: Recent Advances and Future Perspectives. Biomedicines, 13.","DOI":"10.3390\/biomedicines13020368"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S2213-8587(24)00316-4","article-title":"Definition and diagnostic criteria of clinical obesity","volume":"13","author":"Rubino","year":"2025","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"505","DOI":"10.2337\/dc08-1382","article-title":"Association of lifestyle factors with abdominal subcutaneous and visceral adiposity: The Framingham Heart Study","volume":"32","author":"Molenaar","year":"2009","journal-title":"Diabetes Care"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1467-789X.2009.00623.x","article-title":"Subcutaneous and visceral adipose tissue: Structural and functional differences","volume":"11","author":"Ibrahim","year":"2010","journal-title":"Obes. Rev."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1161\/CIRCRESAHA.120.316101","article-title":"Obesity Phenotypes, Diabetes, and Cardiovascular Diseases","volume":"126","author":"Tchernof","year":"2020","journal-title":"Circ. Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.mayocp.2013.11.011","article-title":"A pooled analysis of waist circumference and mortality in 650,000 adults","volume":"89","author":"Cerhan","year":"2014","journal-title":"Mayo Clin. Proc."},{"key":"ref_8","first-page":"1375","article-title":"Impact of waist-to-hip and waist-to-height ratios on physical performance: Insights from the Longevity Check-up 8+ project","volume":"17","author":"Martone","year":"2025","journal-title":"Aging"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3345\/kjp.2016.59.11.425","article-title":"Waist-to-height ratio as a screening tool for obesity and cardiometabolic risk","volume":"59","author":"Yoo","year":"2016","journal-title":"Korean J. Pediatr."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1038\/s41598-024-52645-9","article-title":"Cutoffs of different body measurement indexes of central obesity in patients with type 2 diabetes","volume":"14","author":"Luo","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.jclinepi.2007.08.012","article-title":"Indices of abdominal obesity are better discriminators of cardiovascular risk factors than BMI: A meta-analysis","volume":"61","author":"Lee","year":"2008","journal-title":"J. Clin. Epidemiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"101426","DOI":"10.1016\/j.tjnut.2026.101426","article-title":"Novel Waist-to-Height Ratio Estimated Fat Mass Pediatric Cut-offs Predict Hypertension Better than Body Mass Index in Multiracial United States Youths and Adults: The National Health and Nutrition Examination Survey 2015-2023 Cycle","volume":"156","author":"Ali","year":"2026","journal-title":"J. Nutr."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1007\/s13679-024-00580-1","article-title":"Strengths and Limitations of BMI in the Diagnosis of Obesity: What is the Path Forward?","volume":"13","author":"Sweatt","year":"2024","journal-title":"Curr. Obes. Rep."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Krakauer, N.Y., and Krakauer, J.C. (2012). A new body shape index predicts mortality hazard independently of body mass index. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0039504"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s11897-025-00709-w","article-title":"Relative Fat Mass: Refining Adiposity Measurement in the Era Beyond Body Mass Index","volume":"22","author":"Suthahar","year":"2025","journal-title":"Curr. Heart Fail. Rep."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/s41366-019-0516-8","article-title":"Defining cutoffs to diagnose obesity using the relative fat mass (RFM): Association with mortality in NHANES 1999-2014","volume":"44","author":"Woolcott","year":"2020","journal-title":"Int. J. Obes."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejim.2022.12.024","article-title":"Associations of relative fat mass, a new index of adiposity, with type-2 diabetes in the general population","volume":"109","author":"Suthahar","year":"2023","journal-title":"Eur. J. Intern. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0140-6736(03)15268-3","article-title":"Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies","volume":"363","author":"Tan","year":"2004","journal-title":"Lancet"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S2213-8587(21)00088-7","article-title":"Ethnicity-specific BMI cutoffs for obesity based on type 2 diabetes risk in England: A population-based cohort study","volume":"9","author":"Caleyachetty","year":"2021","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.2337\/diacare.26.5.1380","article-title":"Cutoff Values for Normal Anthropometric Variables in Asian Indian Adults","volume":"26","author":"Snehalatha","year":"2003","journal-title":"Diabetes Care"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Wu, Y., Li, D., and Vermund, S.H. (2024). Advantages and Limitations of the Body Mass Index (BMI) to Assess Adult Obesity. Int. J. Environ. Res. Public Health, 21.","DOI":"10.3390\/ijerph21060757"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e000188","DOI":"10.1136\/bmjdrc-2015-000188","article-title":"Indirect measure of visceral adiposity \u2018A Body Shape Index\u2019 (ABSI) is associated with arterial stiffness in patients with type 2 diabetes","volume":"4","author":"Bouchi","year":"2016","journal-title":"BMJ Open Diabetes Res. Care"},{"key":"ref_23","unstructured":"World Health Organization (2011). Waist Circumference and Waist-Hip Ratio: Report of a WHO Expert Consultation, Geneva, 8\u201311 December 2008."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/oby.2007.612","article-title":"Minimal versus umbilical waist circumference measures as indicators of cardiovascular disease risk","volume":"15","author":"Willis","year":"2007","journal-title":"Obesity"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1038\/sj.ijo.0803566","article-title":"Waist circumference of healthy men and women in the United States","volume":"31","author":"Flegal","year":"2007","journal-title":"Int. J. Obes."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.2337\/dc12-1452","article-title":"Measurement of Waist Circumference: Midabdominal or iliac crest?","volume":"36","author":"Ma","year":"2013","journal-title":"Diabetes Care"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1093\/ajcn\/77.2.379","article-title":"Comparisons of waist circumferences measured at 4 sites","volume":"77","author":"Wang","year":"2003","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/s41574-019-0310-7","article-title":"Waist circumference as a vital sign in clinical practice: A Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity","volume":"16","author":"Ross","year":"2020","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1038\/s41366-023-01380-8","article-title":"Relative fat mass and prediction of incident atrial fibrillation, heart failure and coronary artery disease in the general population","volume":"47","author":"Zwartkruis","year":"2023","journal-title":"Int. J. Obes."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.21037\/qims.2020.02.06","article-title":"MRI in the assessment of adipose tissues and muscle composition: How to use it","volume":"10","author":"Huber","year":"2020","journal-title":"Quant. Imaging Med. Surg."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.clnesp.2022.01.009","article-title":"Computed tomography reference values for visceral obesity and increased metabolic risk in a Caucasian cohort","volume":"48","author":"Baggerman","year":"2022","journal-title":"Clin. Nutr. ESPEN"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/s41366-021-00743-3","article-title":"Age- and sex-specific visceral fat reference cutoffs and their association with cardio-metabolic risk","volume":"45","author":"Taylor","year":"2021","journal-title":"Int. J. Obes."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e1103","DOI":"10.1210\/clinem\/dgae341","article-title":"Defining Overweight and Obesity by Percent Body Fat Instead of Body Mass Index","volume":"110","author":"Potter","year":"2025","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1038\/oby.2011.367","article-title":"Dual-Energy X-Ray Performs as Well as Clinical Computed Tomography for the Measurement of Visceral Fat","volume":"20","author":"Micklesfield","year":"2012","journal-title":"Obesity"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1038\/oby.2009.14","article-title":"Body composition measured by dual-energy X-ray absorptiometry half-body scans in obese adults","volume":"17","author":"Rothney","year":"2009","journal-title":"Obesity"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1749-6632.2000.tb06441.x","article-title":"Bioelectrical impedance analysis. What does it measure?","volume":"904","author":"Schoeller","year":"2000","journal-title":"Ann. N. Y Acad. Sci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/sj.ejcn.1602545","article-title":"Comparison between bioelectrical impedance analysis and body mass index methods in determination of obesity prevalence in Ahvazi women","volume":"61","author":"Amani","year":"2007","journal-title":"Eur. J. Clin. Nutr."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Li, Y.C., Li, C.I., Lin, W.Y., Liu, C.S., Hsu, H.S., Lee, C.C., Chen, F.N., Li, T.C., and Lin, C.C. (2013). Percentage of body fat assessment using bioelectrical impedance analysis and dual-energy X-ray absorptiometry in a weight loss program for obese or overweight Chinese adults. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0058272"},{"key":"ref_39","first-page":"329","article-title":"Limitations and validation of bioelectrical impedance analysis in morbidly obese patients","volume":"8","author":"Coppini","year":"2005","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1161\/HYPERTENSIONAHA.116.07306","article-title":"Abdominal Adiposity Distribution Quantified by Ultrasound Imaging and Incident Hypertension in a General Population","volume":"68","author":"Seven","year":"2016","journal-title":"Hypertension"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1111\/dom.70390","article-title":"Ultrasound and MRI abdominal fat distribution and its associations with metabolic conditions in adults with abdominal obesity","volume":"28","author":"Queral","year":"2026","journal-title":"Diabetes Obes. Metab."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"78","DOI":"10.14196\/mjiri.32.78","article-title":"Is ultrasound-measured abdominal fat thickness a reliable method for predicting metabolic diseases in obese and overweight women?","volume":"32","author":"Angoorani","year":"2018","journal-title":"Med. J. Islam. Repub. Iran."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s00261-006-9082-3","article-title":"Sonographic subcutaneous and visceral fat indices represent the distribution of body fat volume","volume":"32","author":"Koda","year":"2007","journal-title":"Abdom. Imaging"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.2214\/AJR.07.2366","article-title":"Sonographic assessment of regional adiposity","volume":"189","author":"Vlachos","year":"2007","journal-title":"AJR Am. J. Roentgenol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.ultrasmedbio.2011.05.844","article-title":"A simple ultrasound correlate of visceral fat","volume":"37","author":"Oh","year":"2011","journal-title":"Ultrasound Med. Biol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"109314","DOI":"10.1016\/j.jdiacomp.2026.109314","article-title":"Ultrasound assessment of abdominal fat: Subcutaneous maximum thickness as a practical marker of metabolic risk in primary care","volume":"40","author":"Perdomo","year":"2026","journal-title":"J. Diabetes Its Complicat."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"63","DOI":"10.4236\/ojemd.2012.24010","article-title":"Evaluation of Visceral and Subcutaneous Fat by Ultrasound and Its Relationship with Clinical and Metabolic Parameters of Insulin Resistance and Subclinical Atherosclerosis","volume":"2","author":"Prado","year":"2012","journal-title":"Open J. Endocr. Metab. Dis."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"22740","DOI":"10.1038\/s41598-021-02208-z","article-title":"Ultrasound estimated subcutaneous and visceral adipose tissue thicknesses and risk of pre-eclampsia","volume":"11","author":"Junus","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2214\/AJR.20.23049","article-title":"Utilizing Fully Automated Abdominal CT-Based Biomarkers for Opportunistic Screening for Metabolic Syndrome in Adults Without Symptoms","volume":"216","author":"Pickhardt","year":"2021","journal-title":"AJR Am. J. Roentgenol."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Guo, X.L., Tu, M., Chen, Y., and Wang, W. (2022). Perirenal Fat Thickness: A Surrogate Marker for Metabolic Syndrome in Chinese Newly Diagnosed Type 2 Diabetes. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.850334"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e43584","DOI":"10.1097\/MD.0000000000043584","article-title":"Preperitoneal fat thickness as a potential noninvasive marker for metabolic-associated liver disease: A retrospective study","volume":"104","author":"Sezer","year":"2025","journal-title":"Medicine"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.orcp.2026.03.001","article-title":"Ultrasound-measured visceral adipose tissue thickness and carotid atherosclerosis in patients with inflammatory bowel diseases","volume":"20","author":"Genkel","year":"2026","journal-title":"Obes. Res. Clin. Pract."},{"key":"ref_53","unstructured":"Manikandan, K.A., Ahmad, Y., Syed, S., and Nanda, N. (2026). Epicardial Adipose Tissue: Clinical Biomarker of Cardio-Metabolic Risk. Cardiometabolic Medicine, Jaypee Brothers."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.2196\/medinform.4923","article-title":"Computerized Automated Quantification of Subcutaneous and Visceral Adipose Tissue from Computed Tomography Scans: Development and Validation Study","volume":"4","author":"Kim","year":"2016","journal-title":"JMIR Med. Inform."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Hsieh, Y.J., Hsieh, T.J., Ho, C.H., Weng, K.H., and Chou, Y.C. (2026). Clinical Usefulness and Cut-Off Value of Computed Tomography-Measured Visceral Adipose Tissue in Coronary Artery Disease. Diagnostics, 16.","DOI":"10.3390\/diagnostics16030483"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"101679","DOI":"10.1016\/j.jocd.2026.101679","article-title":"Visceral adipose tissue in obesity: A comparison between DXA and MRI measures","volume":"29","author":"Bolan","year":"2026","journal-title":"J. Clin. Densitom."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1038\/s41366-026-02037-y","article-title":"Weight-related changes in MRI-derived measures of body composition and liver steatosis: A large-scale analysis for obesity trial design","volume":"50","author":"Nowak","year":"2026","journal-title":"Int. J. Obes."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"128","DOI":"10.36011\/cpp.2024.6.e13","article-title":"Use of dual-energy x-ray absorptiometry for body composition in chronic disease management","volume":"6","author":"Kim","year":"2024","journal-title":"Cardiovasc. Prev. Pharmacother."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S2213-8587(13)70183-9","article-title":"Bone loss after bariatric surgery: Causes, consequences, and management","volume":"2","author":"Stein","year":"2014","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1136\/bmj.38470.670903.E0","article-title":"Early life risk factors for obesity in childhood: Cohort study","volume":"330","author":"Reilly","year":"2005","journal-title":"BMJ"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/s42255-026-01497-w","article-title":"The genetics of obesity: Aetiology, prevention and therapy","volume":"8","author":"Bonnefond","year":"2026","journal-title":"Nat. Metab."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"284","DOI":"10.7861\/clinmed.2023-0168","article-title":"Causes of obesity: A review","volume":"23","author":"Masood","year":"2023","journal-title":"Clin. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.maturitas.2011.02.018","article-title":"Genetics and epigenetics of obesity","volume":"69","author":"Herrera","year":"2011","journal-title":"Maturitas"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/oby.23116","article-title":"Genetics of Obesity: What We Have Learned over Decades of Research","volume":"29","author":"Bouchard","year":"2021","journal-title":"Obesity"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1210\/endrev\/bnaf004","article-title":"Antiobesity Pharmacotherapy for Patients with Genetic Obesity Due to Defects in the Leptin-Melanocortin Pathway","volume":"46","author":"Welling","year":"2025","journal-title":"Endocr. Rev."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.12998\/wjcc.v8.i18.4169","article-title":"Insulinoma presenting with postprandial hypoglycemia and a low body mass index: A case report","volume":"8","author":"Kalman","year":"2020","journal-title":"World J. Clin. Cases"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"102394","DOI":"10.1016\/j.bpobgyn.2023.102394","article-title":"Endocrine disorders associated with obesity","volume":"90","author":"Park","year":"2023","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1210\/en.2006-0736","article-title":"Hyaluronan Accumulation in Thyroid Tissue: Evidence for Contributions from Epithelial Cells and Fibroblasts","volume":"148","author":"Gianoukakis","year":"2007","journal-title":"Endocrinology"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"bqab155","DOI":"10.1210\/endocr\/bqab155","article-title":"Obesity, POMC, and POMC-processing Enzymes: Surprising Results from Animal Models","volume":"162","author":"Lindberg","year":"2021","journal-title":"Endocrinology"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"505","DOI":"10.5009\/gnl.2013.7.5.505","article-title":"Role of ghrelin in the pathophysiology of gastrointestinal disease","volume":"7","author":"Cheung","year":"2013","journal-title":"Gut Liver"},{"key":"ref_71","first-page":"1047","article-title":"Ghrelin and Obesity: Identifying Gaps and Dispelling Myths. A Reappraisal","volume":"31","author":"Makris","year":"2017","journal-title":"Vivo"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1210\/jc.2004-1216","article-title":"Postprandial plasma ghrelin is suppressed proportional to meal calorie content in normal-weight but not obese subjects","volume":"90","author":"Patterson","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.jacc.2020.11.069","article-title":"Leptin in Leanness and Obesity: JACC State-of-the-Art Review","volume":"77","author":"Perakakis","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"e250521","DOI":"10.1530\/EC-25-0521","article-title":"Leptin and leptin resistance in obesity: Current evidence, mechanisms and future directions","volume":"14","author":"Hu","year":"2025","journal-title":"Endocr. Connect."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/s41575-020-0341-5","article-title":"Brain-gut-microbiome interactions in obesity and food addiction","volume":"17","author":"Gupta","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.trsl.2016.10.002","article-title":"Feeding the microbiota-gut-brain axis: Diet, microbiome, and neuropsychiatry","volume":"179","author":"Sandhu","year":"2017","journal-title":"Transl. Res."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/bies.201400071","article-title":"Is eating behavior manipulated by the gastrointestinal microbiota? Evolutionary pressures and potential mechanisms","volume":"36","author":"Alcock","year":"2014","journal-title":"Bioessays"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1038\/s41390-025-04113-x","article-title":"Psychosocial factors and the development of childhood overweight and obesity: A UK cohort study","volume":"98","author":"Putra","year":"2025","journal-title":"Pediatr. Res."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nri.2015.5","article-title":"The role of inflammation in depression: From evolutionary imperative to modern treatment target","volume":"16","author":"Miller","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"100585","DOI":"10.1016\/j.obmed.2025.100585","article-title":"Cytokines as key players in obesity low grade inflammation and related complications","volume":"54","author":"Uti","year":"2025","journal-title":"Obes. Med."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Monsalve, F.A., Fern\u00e1ndez-Tapia, B., Arriagada, O.C., Gonz\u00e1lez, D.R., and Delgado-L\u00f3pez, F. (2025). Obesity and Depression: A Pathophysiotoxic Relationship. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms262311590"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.foodpol.2004.02.004","article-title":"Dietary habits, demographics, and the development of overweight and obesity among children in the United States","volume":"30","author":"Boumtje","year":"2005","journal-title":"Food Policy"},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Moschonis, G., and Trakman, G.L. (2023). Overweight and Obesity: The Interplay of Eating Habits and Physical Activity. Nutrients, 15.","DOI":"10.3390\/nu15132896"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"e12935","DOI":"10.1111\/obr.12935","article-title":"The association between weight stigma and mental health: A meta-analysis","volume":"21","author":"Emmer","year":"2020","journal-title":"Obes. Rev."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1177\/0956797615601103","article-title":"Weight Discrimination and Risk of Mortality","volume":"26","author":"Sutin","year":"2015","journal-title":"Psychol. Sci."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s13679-023-00495-3","article-title":"Obesity Stigma: Causes, Consequences, and Potential Solutions","volume":"12","author":"Westbury","year":"2023","journal-title":"Curr. Obes. Rep."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.2105\/AJPH.93.8.1342","article-title":"Portrayals of overweight and obese individuals on commercial television","volume":"93","author":"Greenberg","year":"2003","journal-title":"Am. J. Public Health"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"e13606","DOI":"10.1111\/obr.13606","article-title":"Weight stigma experienced by patients with obesity in healthcare settings: A qualitative evidence synthesis","volume":"24","author":"Ryan","year":"2023","journal-title":"Obes. Rev."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1249\/MSS.0b013e3181949333","article-title":"Appropriate Physical Activity Intervention Strategies for Weight Loss and Prevention of Weight Regain for Adults","volume":"41","author":"Donnelly","year":"2009","journal-title":"Med. Sci. Sports Exerc."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1001\/jama.2018.14854","article-title":"The Physical Activity Guidelines for Americans","volume":"320","author":"Piercy","year":"2018","journal-title":"JAMA"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"e2452185","DOI":"10.1001\/jamanetworkopen.2024.52185","article-title":"Aerobic Exercise and Weight Loss in Adults: A Systematic Review and Dose-Response Meta-Analysis","volume":"7","author":"Jayedi","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1056\/NEJMoa2028198","article-title":"Healthy Weight Loss Maintenance with Exercise, Liraglutide, or Both Combined","volume":"384","author":"Janus","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Sun, J., Ruan, Y., Xu, N., Wu, P., Lin, N., Yuan, K., An, S., Kang, P., Li, S., and Huang, Q. (2023). The effect of dietary carbohydrate and calorie restriction on weight and metabolic health in overweight\/obese individuals: A multi-center randomized controlled trial. BMC Med., 21.","DOI":"10.1186\/s12916-023-02869-9"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"k4583","DOI":"10.1136\/bmj.k4583","article-title":"Effects of a low carbohydrate diet on energy expenditure during weight loss maintenance: Randomized trial","volume":"363","author":"Ebbeling","year":"2018","journal-title":"BMJ"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.jand.2017.06.006","article-title":"Practice Paper of the Academy of Nutrition and Dietetics: Classic and Modified Ketogenic Diets for Treatment of Epilepsy","volume":"117","author":"Roehl","year":"2017","journal-title":"J. Acad. Nutr. Diet."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"100495","DOI":"10.1016\/j.ajpc.2023.100495","article-title":"Dramatic elevation of LDL cholesterol from ketogenic-dieting: A Case Series","volume":"14","author":"Schmidt","year":"2023","journal-title":"Am. J. Prev. Cardiol."},{"key":"ref_97","first-page":"1","article-title":"Randomized control trial evaluation of a modified Paleolithic dietary intervention in the treatment of relapsing-remitting multiple sclerosis: A pilot study","volume":"7","author":"Irish","year":"2017","journal-title":"Degener. Neurol. Neuromuscul. Dis."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Fr\u0105czek, B., Pi\u0119ta, A., Burda, A., Mazur-Kurach, P., and Tyra\u0142a, F. (2021). Paleolithic Diet-Effect on the Health Status and Performance of Athletes?. Nutrients, 13.","DOI":"10.3390\/nu13031019"},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Akan, O.D., Qin, D., Guo, T., Lin, Q., and Luo, F. (2022). Sirtfoods: New Concept Foods, Functions, and Mechanisms. Foods, 11.","DOI":"10.3390\/foods11192955"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12986-024-00798-9","article-title":"Sirtfood intake in relation to the 10-year risk of major adverse cardiovascular events: A population-based cohort study","volume":"21","author":"Golzarand","year":"2024","journal-title":"Nutr. Metab."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1017\/S1368980011002515","article-title":"Mediterranean diet pyramid today. Science and cultural updates","volume":"14","author":"Berry","year":"2011","journal-title":"Public Health Nutr."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00394-017-1582-0","article-title":"Mediterranean diet and cardiovascular disease: A systematic review and meta-analysis of observational studies","volume":"58","author":"Rosato","year":"2019","journal-title":"Eur. J. Nutr."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s11154-020-09579-0","article-title":"The role of the Mediterranean diet on weight loss and obesity-related diseases","volume":"21","author":"Estruch","year":"2020","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1249\/MSS.0b013e31817d8176","article-title":"Weight regain is related to decreases in physical activity during weight loss","volume":"40","author":"Wang","year":"2008","journal-title":"Med. Sci. Sports Exerc."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP161365.GL","article-title":"American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines for Medical Care of Patients with Obesity","volume":"22","author":"Garvey","year":"2016","journal-title":"Endocr. Pract."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s13679-023-00546-9","article-title":"Phentermine in the Modern Era of Obesity Pharmacotherapy: Does It Still Have a Role in Treatment?","volume":"13","author":"Lewis","year":"2024","journal-title":"Curr. Obes. Rep."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"298","DOI":"10.4082\/kjfm.2013.34.5.298","article-title":"Postmarketing surveillance study of the efficacy and safety of phentermine in patients with obesity","volume":"34","author":"Kim","year":"2013","journal-title":"Korean J. Fam. Med."},{"key":"ref_108","first-page":"S12","article-title":"Mode of action of orlistat","volume":"21","author":"Guerciolini","year":"1997","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2165\/00002018-200831010-00005","article-title":"Orlistat-associated adverse effects and drug interactions: A critical review","volume":"31","author":"Filippatos","year":"2008","journal-title":"Drug Saf."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1001\/jama.2024.18189","article-title":"Medications for Obesity","volume":"333","author":"Voelker","year":"2025","journal-title":"JAMA"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/oby.2010.147","article-title":"Weight loss with naltrexone SR\/bupropion SR combination therapy as an adjunct to behavior modification: The COR-BMOD trial","volume":"19","author":"Wadden","year":"2011","journal-title":"Obesity"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1411892","article-title":"A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management","volume":"373","author":"Astrup","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-Weekly Semaglutide in Adults with Overweight or Obesity","volume":"384","author":"Calanna","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_114","first-page":"e94126","article-title":"Allodynia and Dysesthesia Associated with Semaglutide and Tirzepatide","volume":"17","author":"Ahern","year":"2025","journal-title":"Cureus"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S2213-8587(25)00225-6","article-title":"Once-weekly semaglutide 7\u00b72 mg in adults with obesity and type 2 diabetes (STEP UP T2D): A randomised, controlled, phase 3b trial","volume":"13","author":"Lingvay","year":"2025","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.59556\/japi.74.1375","article-title":"National Consensus on Semaglutide in Cardiology: From Clinical Evidence to Clinical Translation","volume":"74","author":"Chopra","year":"2026","journal-title":"J. Assoc. Physicians India"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0140-6736(23)01185-6","article-title":"Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): A randomised, double-blind, placebo-controlled, phase 3 trial","volume":"402","author":"Knop","year":"2023","journal-title":"Lancet"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1001\/jama.2026.0035","article-title":"What to Know About the New Semaglutide Pill for Obesity","volume":"335","author":"Schweitzer","year":"2026","journal-title":"JAMA"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1056\/NEJMoa2500969","article-title":"Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity","volume":"393","author":"Wharton","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"bvad016","DOI":"10.1210\/jendso\/bvad016","article-title":"Adverse Events Related to Tirzepatide","volume":"7","author":"Mishra","year":"2023","journal-title":"J. Endocr. Soc."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/s41586-026-10330-z","article-title":"Genetic predictors of GLP1 receptor agonist weight loss and side effects","volume":"653","author":"Su","year":"2026","journal-title":"Nature"},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Batsis, J.A., Gavras, A., Gross, D.C., Cheever, C.R., Da Silva, B.R., Meira Filho, L.F., Jones, E.P., Batchek, D., Khandpekar, S., and Patel, R. (2026). Effect of Incretin-Based and Nonpharmacologic Weight Loss on Body Composition. Ann. Intern. Med.","DOI":"10.7326\/ANNALS-25-00478"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"e085304","DOI":"10.1136\/bmj-2025-085304","article-title":"Weight regain after cessation of medication for weight management: Systematic review and meta-analysis","volume":"392","author":"West","year":"2026","journal-title":"BMJ"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"5339","DOI":"10.1111\/dom.70633","article-title":"Prevention of Weight Regain After GLP1RA Cessation with Oral TIX100","volume":"28","author":"Jo","year":"2026","journal-title":"Diabetes Obes. Metab."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s002280050433","article-title":"Efficacy and tolerability of orlistat in the treatment of obesity: A 6-month dose-ranging study. Orlistat Dose-Ranging Study Group","volume":"54","author":"Broom","year":"1998","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1111\/dom.16119","article-title":"Evaluation of the efficacy and safety of controlled-release phentermine\/topiramate in adults with obesity in Korea: A randomized, double-blind, placebo-controlled, phase 4 trial (QUEEN\u2019s study)","volume":"27","author":"Hong","year":"2025","journal-title":"Diabetes Obes. Metab."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1056\/NEJMoa2301972","article-title":"Triple\u2013Hormone-Receptor Agonist Retatrutide for Obesity\u2014A Phase 2 Trial","volume":"389","author":"Jastreboff","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1056\/NEJMoa2511774","article-title":"Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment","volume":"393","author":"Wharton","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1056\/NEJMoa2502082","article-title":"Cagrilintide\u2013Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes","volume":"393","author":"Broholm","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S2213-8587(24)00273-0","article-title":"Setmelanotide in patients aged 2-5 years with rare MC4R pathway-associated obesity (VENTURE): A 1 year, open-label, multicenter, phase 3 trial","volume":"13","author":"Argente","year":"2025","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1001\/jamasurg.2025.3590","article-title":"Obesity Treatment with Bariatric Surgery vs GLP-1 Receptor Agonists","volume":"160","author":"Barrett","year":"2025","journal-title":"JAMA Surg."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1001\/jama.303.6.576","article-title":"Bariatric Surgery","volume":"303","author":"Torpy","year":"2010","journal-title":"JAMA"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1001\/jama.2019.14231","article-title":"Association of Metabolic Surgery with Major Adverse Cardiovascular Outcomes in Patients with Type 2 Diabetes and Obesity","volume":"322","author":"Aminian","year":"2019","journal-title":"JAMA"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1097\/SLA.0b013e31826e1846","article-title":"Alterations in gut hormones after laparoscopic sleeve gastrectomy: A prospective clinical and laboratory investigational study","volume":"257","author":"Dimitriadis","year":"2013","journal-title":"Ann. Surg."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/ajcn\/52.1.87","article-title":"Changes in eating behavior after horizontal gastroplasty and Roux-en-Y gastric bypass","volume":"52","author":"Kenler","year":"1990","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1177\/193229681100500536","article-title":"Mechanisms responsible for excess weight loss after bariatric surgery","volume":"5","author":"Ionut","year":"2011","journal-title":"J. Diabetes Sci. Technol."},{"key":"ref_137","unstructured":"Burjonrappa, S., and Grover, K. (2026). Bariatric Surgery Complications. StatPearls, StatPearls Publishing."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nrgastro.2009.148","article-title":"Pathophysiology, diagnosis and management of postoperative dumping syndrome","volume":"6","author":"Tack","year":"2009","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"100655","DOI":"10.1016\/j.cpcardiol.2020.100655","article-title":"Obesity and Coronary Heart Disease: Epidemiology, Pathology, and Coronary Artery Imaging","volume":"46","author":"Katta","year":"2021","journal-title":"Curr. Probl. Cardiol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","article-title":"Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study","volume":"364","author":"Yusuf","year":"2004","journal-title":"Lancet"},{"key":"ref_141","unstructured":"Ahmad, Y., Mendpara, V., Jaganathan, V., Nanda, N., and Chopra, H. (2026). Echocardiographic Assessment of Epicardial Adipose Tissue in Cardiovascular Disease and Associated Risk Factors. Advances in Obesity and Lipid Management in CVD, Jaypee Brothers."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"e038484","DOI":"10.1161\/JAHA.124.038484","article-title":"Epicardial Fat Tissue: A Potential Marker for Coronary Microvascular Dysfunction","volume":"14","author":"Abusnina","year":"2025","journal-title":"J. Am. Heart Assoc."},{"key":"ref_143","first-page":"1753","article-title":"Clinical Role of Epicardial Adipose Tissue","volume":"41","author":"Raggi","year":"2025","journal-title":"Can. J. Cardiol."},{"key":"ref_144","unstructured":"Wasan, R., Spanova, J., Nanda, N., Wasan, A., Nanda, A., Nanda, N., and Chopra, H. (2026). Association Between Autoimmunity, Obesity, and Atherosclerosis\/Cardiovascular Disease, Jaypee Brothers."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s13679-023-00510-7","article-title":"Obesity and Peripheral Artery Disease: Current Evidence and Controversies","volume":"12","author":"Lempesis","year":"2023","journal-title":"Curr. Obes. Rep."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1161\/STROKEAHA.111.639922","article-title":"Obesity","volume":"44","author":"Kernan","year":"2013","journal-title":"Stroke"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","article-title":"Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes","volume":"389","author":"Lincoff","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"e032277","DOI":"10.1161\/JAHA.123.032277","article-title":"Impact of Obesity on Atrial Fibrillation Pathogenesis and Treatment Options","volume":"13","author":"Sha","year":"2024","journal-title":"J. Am. Heart Assoc."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1161\/CIRCULATIONAHA.110.009035","article-title":"Absolute and attributable risks of atrial fibrillation in relation to optimal and borderline risk factors: The Atherosclerosis Risk in Communities (ARIC) study","volume":"123","author":"Huxley","year":"2011","journal-title":"Circulation"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jacep.2015.04.004","article-title":"Obesity and the Risk of Incident, Post-Operative, and Post-Ablation Atrial Fibrillation: A Meta-Analysis of 626,603 Individuals in 51 Studies","volume":"1","author":"Wong","year":"2015","journal-title":"JACC Clin. Electrophysiol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/j.jacc.2010.11.045","article-title":"Pericardial Fat Is Associated with Atrial Fibrillation Severity and Ablation Outcome","volume":"57","author":"Wong","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"467","DOI":"10.4065\/76.5.467","article-title":"Left atrial volume: Important risk marker of incident atrial fibrillation in 1655 older men and women","volume":"76","author":"Tsang","year":"2001","journal-title":"Mayo Clin. Proc."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.hlc.2025.08.003","article-title":"Obesity and Atrial Fibrillation: From Mechanisms to Treatment","volume":"34","author":"Dziano","year":"2025","journal-title":"Heart Lung Circ."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/s41569-022-00679-9","article-title":"Epicardial adipose tissue in contemporary cardiology","volume":"19","author":"Iacobellis","year":"2022","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"euag018","DOI":"10.1093\/europace\/euag018","article-title":"Semaglutide as adjunctive therapy to catheter ablation in obesity-related paroxysmal atrial fibrillation","volume":"28","author":"Ciconte","year":"2026","journal-title":"Europace"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1161\/CIRCULATIONAHA.117.028365","article-title":"Obese Heart Failure with Preserved Ejection Fraction Phenotype","volume":"136","author":"Kitzman","year":"2017","journal-title":"Circulation"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"103046","DOI":"10.1016\/j.jchf.2026.103046","article-title":"Excess and Dysfunctional Fat as a Primary Driver of Heart Failure with Preserved Ejection Fraction","volume":"14","author":"Packer","year":"2026","journal-title":"JACC Heart Fail."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.jchf.2018.05.018","article-title":"The Association of Obesity and Cardiometabolic Traits with Incident HFpEF and HFrEF","volume":"6","author":"Savji","year":"2018","journal-title":"JACC Heart Fail."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1056\/NEJMoa2306963","article-title":"Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity","volume":"389","author":"Kosiborod","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/nrcardio.2016.163","article-title":"Neurohormonal activation in heart failure with reduced ejection fraction","volume":"14","author":"Hartupee","year":"2017","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/0002-9149(92)90739-L","article-title":"Cardiomyopathy of obesity: A clinicopathologic evaluation of 43 obese patients with heart failure","volume":"70","author":"Kasper","year":"1992","journal-title":"Am. J. Cardiol."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1016\/j.jacc.2026.02.5083","article-title":"Obesity and Heart Failure with Reduced Ejection Fraction: A Review","volume":"87","author":"Khan","year":"2026","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_163","unstructured":"Spanova, J., Wasan, R., Nanda, N., Nanda, N., and Chopra, H. (2026). Obesity Review: New Dimensions, Jaypee Brothers."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1053\/j.ackd.2014.12.004","article-title":"Obesity and insulin resistance in resistant hypertension: Implications for the kidney","volume":"22","author":"Rao","year":"2015","journal-title":"Adv. Chronic Kidney Dis."},{"key":"ref_165","doi-asserted-by":"crossref","unstructured":"Barboza, J.J., Huam\u00e1n, M.R., Melgar, B., Diaz-Arocutipa, C., Valenzuela-Rodriguez, G., and Hernandez, A.V. (2022). Efficacy of Liraglutide in Non-Diabetic Obese Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J. Clin. Med., 11.","DOI":"10.3390\/jcm11112998"},{"key":"ref_166","doi-asserted-by":"crossref","unstructured":"Kennedy, C., Hayes, P., Salama, S., Hennessy, M., and Fogacci, F. (2023). The Effect of Semaglutide on Blood Pressure in Patients without Diabetes: A Systematic Review and Meta-Analysis. J. Clin. Med., 12.","DOI":"10.3390\/jcm12030772"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1161\/CIRCRESAHA.125.325676","article-title":"Obstructive Sleep Apnea and Cardiometabolic Disease: Obesity, Hypertension, and Diabetes","volume":"137","author":"Tasali","year":"2025","journal-title":"Circ. Res."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.mcna.2010.02.003","article-title":"Cardiovascular consequences of obese and nonobese obstructive sleep apnea","volume":"94","author":"Ramar","year":"2010","journal-title":"Med. Clin. N. Am."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s13665-025-00384-1","article-title":"The Potential Role of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists and Glucose-Dependent Insulinotropic Polypeptide (GIP) Receptor Agonists in Obstructive Sleep Apnea and Obesity","volume":"14","author":"Ellberg","year":"2025","journal-title":"Curr. Pulmonol. Rep."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1056\/NEJMoa2404881","article-title":"Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity","volume":"391","author":"Malhotra","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/osp4.629","article-title":"Obesity and chronic kidney disease: A current review","volume":"9","author":"Nawaz","year":"2023","journal-title":"Obes. Sci. Pract."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"F1629","DOI":"10.1152\/ajprenal.00263.2013","article-title":"Adipokines as a link between obesity and chronic kidney disease","volume":"305","author":"Briffa","year":"2013","journal-title":"Am. J. Physiol.-Ren. Physiol."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa2403347","article-title":"Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes","volume":"391","author":"Perkovic","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/2047487319878371","article-title":"Diabetes as a cardiovascular risk factor: An overview of global trends of macro and micro vascular complications","volume":"26","author":"Ceriello","year":"2019","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1161\/CIRCULATIONAHA.122.059595","article-title":"GLP-1 Receptor Agonists for the Reduction of Atherosclerotic Cardiovascular Risk in Patients with Type 2 Diabetes","volume":"146","author":"Marx","year":"2022","journal-title":"Circulation"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.2337\/db09-1694","article-title":"Inhibition of monocyte adhesion to endothelial cells and attenuation of atherosclerotic lesion by a glucagon-like peptide-1 receptor agonist, exendin-4","volume":"59","author":"Arakawa","year":"2010","journal-title":"Diabetes"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/12\/4430\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T16:42:01Z","timestamp":1780936921000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/12\/4430"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,8]]},"references-count":176,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["jcm15124430"],"URL":"https:\/\/doi.org\/10.3390\/jcm15124430","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,8]]}}}